Compare VS & TRIB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VS | TRIB |
|---|---|---|
| Founded | 2013 | 1992 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.9M | 8.4M |
| IPO Year | 2017 | 1996 |
| Metric | VS | TRIB |
|---|---|---|
| Price | $1.07 | $6.32 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 12.5K | 8.0K |
| Earning Date | 11-13-2026 | 06-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 75.97 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,183,415.00 | N/A |
| Revenue This Year | N/A | $35.89 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 3711.30 | N/A |
| 52 Week Low | $0.75 | $0.28 |
| 52 Week High | $2.47 | $14.17 |
| Indicator | VS | TRIB |
|---|---|---|
| Relative Strength Index (RSI) | 40.85 | N/A |
| Support Level | $1.01 | N/A |
| Resistance Level | $1.18 | N/A |
| Average True Range (ATR) | 0.06 | 0.00 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 19.13 | 0.00 |
Versus Systems Inc operates within the technology sector, focusing on engagement-enhancing solutions through its proprietary prizing and promotions platform. This technology enables developers and content creators across streaming, live events, broadcast, gaming, and other media to integrate real-world prizes into their experiences, fostering greater consumer interaction and providing a compelling opportunity for brand partners and advertisers. The company operates in Canada and the USA.
Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has three segments, namely the Americas, Asia/Africa, and Europe, from which it derives a majority of its revenue from the Americas segment.